| scholarly article | Q13442814 |
| P50 | author | Louis Charles Gerstenfeld | Q67658704 |
| P2093 | author name string | G S Stein | |
| J L Stein | |||
| J B Lian | |||
| A Javed | |||
| B O Jasanya | |||
| G L Barnes | |||
| L Gerstenfeld | |||
| P2860 | cites work | Human homologs of a Drosophila Enhancer of split gene product define a novel family of nuclear proteins | Q24324093 |
| Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei | Q27860728 | ||
| Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development | Q28119185 | ||
| A mechanism of repression by acute myeloid leukemia-1, the target of multiple chromosomal translocations in acute leukemia | Q28141676 | ||
| Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation | Q28240596 | ||
| The Groucho/transducin-like enhancer of split transcriptional repressors interact with the genetically defined amino-terminal silencing domain of histone H3 | Q28251560 | ||
| Msx-2/Hox 8.1: a transcriptional regulator of the rat osteocalcin promoter | Q28569869 | ||
| A functional interaction between the histone deacetylase Rpd3 and the corepressor groucho in Drosophila development | Q28609065 | ||
| Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts | Q29547605 | ||
| Characterization of a cDNA for chicken osteopontin: expression during bone development, osteoblast differentiation, and tissue distribution | Q33518738 | ||
| Cooperation among multiple transcription factors is required for access to minimal T-cell receptor alpha-enhancer chromatin in vivo | Q33773382 | ||
| Two domains unique to osteoblast-specific transcription factor Osf2/Cbfa1 contribute to its transactivation function and its inability to heterodimerize with Cbfbeta | Q33774997 | ||
| Analysis of the growth factor requirements for stimulation of WI-38 cells after extended periods of density-dependent growth arrest | Q69500069 | ||
| Structural analysis and characterization of tissue and hormonal responsive expression of the avian bone sialoprotein (BSP) gene | Q73029433 | ||
| Crystal structure of the nuclear matrix targeting signal of the transcription factor acute myelogenous leukemia-1/polyoma enhancer-binding protein 2alphaB/core binding factor alpha2 | Q73176121 | ||
| Sequential expression of bone matrix proteins during rat calvaria osteoblast differentiation and bone nodule formation in vitro | Q73248753 | ||
| CBFa(AML/PEBP2)-related elements in the TGF-beta type I receptor promoter and expression with osteoblast differentiation | Q74530821 | ||
| Kinetics of osteoprogenitor proliferation and osteoblast differentiation in vitro | Q78108341 | ||
| Interaction and functional cooperation of the leukemia-associated factors AML1 and p300 in myeloid cell differentiation | Q33888879 | ||
| Groucho/TLE/R-esp proteins associate with the nuclear matrix and repress RUNX (CBF(alpha)/AML/PEBP2(alpha)) dependent activation of tissue-specific gene transcription | Q33902979 | ||
| Multiple Cbfa/AML sites in the rat osteocalcin promoter are required for basal and vitamin D-responsive transcription and contribute to chromatin organization. | Q33960022 | ||
| Transcriptional control of the tissue-specific, developmentally regulated osteocalcin gene requires a binding motif for the Msx family of homeodomain proteins | Q36010554 | ||
| Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage | Q36235105 | ||
| Identification of a nuclear matrix targeting signal in the leukemia and bone-related AML/CBF-alpha transcription factors | Q36239602 | ||
| Differential roles for bone morphogenetic protein (BMP) receptor type IB and IA in differentiation and specification of mesenchymal precursor cells to osteoblast and adipocyte lineages | Q36256208 | ||
| Nucleation of hydroxyapatite by bone sialoprotein | Q36539546 | ||
| Proviral insertions induce the expression of bone-specific isoforms of PEBP2alphaA (CBFA1): evidence for a new myc collaborating oncogene | Q36552332 | ||
| Characterization of an Avian Bone Sialoprotein (BSP) cDNA: Comparisons to Mammalian BSP and Identification of Conserved Structural Domains | Q36687322 | ||
| Characterization of the human bone sialoprotein (BSP) gene and its promoter sequence | Q36737358 | ||
| An AML-1 consensus sequence binds an osteoblast-specific complex and transcriptionally activates the osteocalcin gene | Q37610593 | ||
| Identification of a minimal sequence of the mouse pro-alpha 1(I) collagen promoter that confers high-level osteoblast expression in transgenic mice and that binds a protein selectively present in osteoblasts | Q37728143 | ||
| A PEBP2 alpha/AML-1-related factor increases osteocalcin promoter activity through its binding to an osteoblast-specific cis-acting element | Q38287692 | ||
| The tissue-specific nuclear matrix protein, NMP-2, is a member of the AML/CBF/PEBP2/runt domain transcription factor family: interactions with the osteocalcin gene promoter | Q38290497 | ||
| Transient upregulation of CBFA1 in response to bone morphogenetic protein-2 and transforming growth factor beta1 in C2C12 myogenic cells coincides with suppression of the myogenic phenotype but is not sufficient for osteoblast differentiation | Q38326843 | ||
| Cloning of a 2.5 kb murine bone sialoprotein promoter fragment and functional analysis of putative Osf2 binding sites | Q38327862 | ||
| Characteristics of vitamin D3 receptor (VDR) binding to the vitamin D response element (VDRE) in rat bone sialoprotein gene promoter | Q38338556 | ||
| Runt homology domain proteins in osteoblast differentiation: AML3/CBFA1 is a major component of a bone-specific complex | Q38344674 | ||
| Bone tissue-specific transcription of the osteocalcin gene: role of an activator osteoblast-specific complex and suppressor hox proteins that bind the OC box. | Q38358091 | ||
| Osteopontin: a protein with diverse functions. | Q40791476 | ||
| Constitutive expression and regulation of collagenase-3 in human breast cancer cells. | Q40868944 | ||
| Identification of a homeodomain binding element in the bone sialoprotein gene promoter that is required for its osteoblast-selective expression | Q40883137 | ||
| CBF alpha3 (AML2) is induced by TGF-beta1 to bind and activate the mouse germline Ig alpha promoter | Q40986530 | ||
| Attachment of osteoblastic cells to hydroxyapatite crystals by a synthetic peptide (Glu7-Pro-Arg-Gly-Asp-Thr) containing two functional sequences of bone sialoprotein | Q41117709 | ||
| The human bone sialoprotein gene contains an NF-E1/YY1 cis-acting sequence with putative regulatory activity | Q41124536 | ||
| AML-2 is a potential target for transcriptional regulation by the t(8;21) and t(12;21) fusion proteins in acute leukemia | Q41183963 | ||
| Comparison of two phosphoproteins in chicken bone and their similarities to the mammalian bone proteins, osteopontin and bone sialoprotein II | Q41714227 | ||
| Tissue specific and vitamin D responsive gene expression in bone. | Q41737437 | ||
| Bone matrix mRNA expression in differentiating fetal bovine osteoblasts | Q42462360 | ||
| Signal transduction pathways mediating parathyroid hormone stimulation of bone sialoprotein gene expression in osteoblasts | Q42527537 | ||
| Sulphation of secreted phosphoprotein I (SPPI, osteopontin) is associated with mineralized tissue formation | Q46274469 | ||
| Mineralization and the expression of matrix proteins during in vivo bone development | Q46291989 | ||
| Rat tibial osteoblasts III: Propagation in vitro is accompanied by enhancement of osteoblast phenotype | Q46292507 | ||
| Ectodermal patterning in the avian embryo: epidermis versus neural plate. | Q52181918 | ||
| Expression of cell growth and bone specific genes at single cell resolution during development of bone tissue-like organization in primary osteoblast cultures. | Q52230731 | ||
| Interactions between the bone matrix proteins osteopontin and bone sialoprotein and the osteoclast integrin alpha v beta 3 potentiate bone resorption | Q58085856 | ||
| Trans-differentiation of hypertrophic chondrocytes into cells capable of producing a mineralized bone matrix | Q67572851 | ||
| Expression of bone sialoprotein (BSP) in developing human tissues | Q67892131 | ||
| Identification and characterization of the major chicken bone phosphoprotein. Analysis of its synthesis by cultured embryonic chick osteoblasts | Q68698684 | ||
| A nonchromatographic assay for expression of the chloramphenicol acetyltransferase gene in eucaryotic cells | Q68733304 | ||
| Expression of differentiated function by mineralizing cultures of chicken osteoblasts | Q68822795 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2891-2905 | |
| P577 | publication date | 2001-04-01 | |
| P1433 | published in | Molecular and Cellular Biology | Q3319478 |
| P1476 | title | runt homology domain transcription factors (Runx, Cbfa, and AML) mediate repression of the bone sialoprotein promoter: evidence for promoter context-dependent activity of Cbfa proteins | |
| P478 | volume | 21 |
| Q44551588 | Ajulemic acid, a nonpsychoactive cannabinoid acid, induces apoptosis in human T lymphocytes |
| Q30872333 | An L1 element disrupts human bone sialoprotein promoter: lack of tissue-specific regulation by distalless5 (Dlx5) and runt homeodomain protein2 (Runx2)/core binding factor a1 (Cbfa1) elements |
| Q52044839 | An in vivo model to study osteogenic gene regulation: targeting an avian retroviral receptor (TVA) to bone with the bone sialoprotein (BSP) promoter. |
| Q33677504 | Applications of transgenics in studies of bone sialoprotein |
| Q21245726 | BGLAP is expressed in pancreatic cancer cells and increases their growth and invasion |
| Q37018563 | BMP-2 differentially modulates FGF-2 isoform effects in osteoblasts from newborn transgenic mice |
| Q35668798 | BMP2 protein regulates osteocalcin expression via Runx2-mediated Atf6 gene transcription |
| Q39950593 | BMP2 regulates Osterix through Msx2 and Runx2 during osteoblast differentiation |
| Q37086321 | Bone morphogenetic protein 2 activates Smad6 gene transcription through bone-specific transcription factor Runx2 |
| Q40680023 | Bone morphogenetic protein-2 inhibits differentiation and mineralization of cementoblasts in vitro |
| Q43773224 | CCAAT/enhancer-binding proteins (C/EBP) beta and delta activate osteocalcin gene transcription and synergize with Runx2 at the C/EBP element to regulate bone-specific expression. |
| Q42280544 | COUP-TFII is required for morphogenesis of the neural crest-derived tympanic ring |
| Q53615857 | Cbf beta regulates Runx2 function isoform-dependently in postnatal bone development. |
| Q28240192 | Cbfa1/RUNX2 directs specific expression of the sclerosteosis gene (SOST) |
| Q28586662 | Cbfbeta interacts with Runx2 and has a critical role in bone development |
| Q35212571 | Context-dependent transcription: all politics is local |
| Q55005787 | Contrasting patterns of RUNX2 repeat variations are associated with palate shape in phyllostomid bats and New World primates. |
| Q37113937 | Cyclin D1-cdk4 induce runx2 ubiquitination and degradation |
| Q43573831 | DDX1 is required for testicular tumorigenesis, partially through the transcriptional activation of 12p stem cell genes |
| Q34620442 | Different effects of BMP-2 on marrow stromal cells from human and rat bone |
| Q46283520 | Differential regulation of dentin sialophosphoprotein expression by Runx2 during odontoblast cytodifferentiation |
| Q36499016 | Dissection of the osteogenic effects of laminin-332 utilizing specific LG domains: LG3 induces osteogenic differentiation, but not mineralization. |
| Q33948578 | Distinct contributions of conserved modules to Runt transcription factor activity |
| Q40523401 | Effects of bone morphogenetic protein-2 and transforming growth factor beta1 on gene expression of transcription factors, AJ18 and Runx2 in cultured osteoblastic cells |
| Q41724496 | Effects of titanium surface anodization with CaP incorporation on human osteoblastic response |
| Q46912279 | Epigallocatechin-3-gallate (EGCG) as a pro-osteogenic agent to enhance osteogenic differentiation of mesenchymal stem cells from human bone marrow: an in vitro study. |
| Q28237966 | Ets-1 and runx2 regulate transcription of a metastatic gene, osteopontin, in murine colorectal cancer cells |
| Q42428362 | Functional analysis of novel RUNX2 mutations in cleidocranial dysplasia |
| Q28236701 | Functional relevance of the BMD-associated polymorphism rs312009: novel involvement of RUNX2 in LRP5 transcriptional regulation |
| Q39013223 | Genomic occupancy of Runx2 with global expression profiling identifies a novel dimension to control of osteoblastogenesis. |
| Q33646195 | Guangxi cobra venom-derived NGF promotes the osteogenic and therapeutic effects of porous BCP ceramic. |
| Q37372149 | HDAC4 represses vascular endothelial growth factor expression in chondrosarcoma by modulating RUNX2 activity |
| Q42921184 | Haploinsufficiency of Runx2 results in bone formation decrease and different BSP expression pattern changes in two transgenic mouse models |
| Q24655929 | Hey1 basic helix-loop-helix protein plays an important role in mediating BMP9-induced osteogenic differentiation of mesenchymal progenitor cells |
| Q40160931 | Human estrogen receptor alpha gene is a target of Runx2 transcription factor in osteoblasts. |
| Q40719108 | Identification of novel protein/DNA interactions within the promoter of the bone-related transcription factor Runx2/Cbfa1. |
| Q37092950 | Impact of human cytomegalovirus latent infection on myeloid progenitor cell gene expression |
| Q33819359 | Impaired intranuclear trafficking of Runx2 (AML3/CBFA1) transcription factors in breast cancer cells inhibits osteolysis in vivo. |
| Q36589550 | In vitro and in vivo synergistic interactions between the Runx2/Cbfa1 transcription factor and bone morphogenetic protein-2 in stimulating osteoblast differentiation |
| Q40655044 | Induction of Osteoclast Differentiation by Runx2 through Receptor Activator of Nuclear Factor-κB Ligand (RANKL) and Osteoprotegerin Regulation and Partial Rescue of Osteoclastogenesis in Runx2–/– Mice by RANKL Transgene |
| Q38758815 | Inhibition of Runx2 signaling by TNF-α in ST2 murine bone marrow stromal cells undergoing osteogenic differentiation |
| Q35042211 | Intranuclear trafficking of transcription factors: Requirements for vitamin D-mediated biological control of gene expression. |
| Q49190271 | Kisspeptin-10 (KP-10) stimulates osteoblast differentiation through GPR54-mediated regulation of BMP2 expression and activation |
| Q39797180 | Novel RUNX2 mutations in Chinese individuals with cleidocranial dysplasia |
| Q64080445 | Overexpression of Dlx2 enhances osteogenic differentiation of BMSCs and MC3T3-E1 cells via direct upregulation of Osteocalcin and Alp |
| Q35071181 | Parathyroid hormone controls receptor activator of NF-kappaB ligand gene expression via a distant transcriptional enhancer |
| Q92501704 | Peroxiredoxin II negatively regulates BMP2-induced osteoblast differentiation and bone formation via PP2A Cα-mediated Smad1/5/9 dephosphorylation |
| Q39935033 | Progressive recruitment of Runx2 to genomic targets despite decreasing expression during osteoblast differentiation |
| Q73393498 | Prostate cancer expression of runt‐domain transcription factor Runx2, a key regulator of osteoblast differentiation and function |
| Q64902344 | RUNX family: Oncogenes or tumor suppressors (Review). |
| Q37325296 | RUNX2 mutations in Chinese patients with cleidocranial dysplasia. |
| Q40572038 | Regulation of tissue inhibitor of metalloproteinase 1 gene transcription by RUNX1 and RUNX2. |
| Q35870162 | Role of (-)-epigallocatechin-3-gallate in the osteogenic differentiation of human bone marrow mesenchymal stem cells: An enhancer or an inducer? |
| Q51097637 | Roles of Runx2 in Skeletal Development. |
| Q24537942 | Runx2 (Cbfa1, AML-3) interacts with histone deacetylase 6 and represses the p21(CIP1/WAF1) promoter |
| Q35779750 | Runx2 control of organization, assembly and activity of the regulatory machinery for skeletal gene expression |
| Q42058727 | Runx2 deficiency in mice causes decreased thyroglobulin expression and hypothyroidism |
| Q44570667 | Runx2 integrates estrogen activity in osteoblasts |
| Q35314247 | Runx2 protein expression utilizes the Runx2 P1 promoter to establish osteoprogenitor cell number for normal bone formation |
| Q34811834 | Runx2, a multifunctional transcription factor in skeletal development |
| Q28254466 | Runx2- and histone deacetylase 3-mediated repression is relieved in differentiating human osteoblast cells to allow high bone sialoprotein expression |
| Q24296392 | Smad6 interacts with Runx2 and mediates Smad ubiquitin regulatory factor 1-induced Runx2 degradation |
| Q34655823 | Small integrin-binding ligand N-linked glycoproteins (SIBLINGs): multifunctional proteins in cancer |
| Q38923789 | Structural coupling of Smad and Runx2 for execution of the BMP2 osteogenic signal. |
| Q37109508 | Subnuclear targeting of Runx/Cbfa/AML factors is essential for tissue-specific differentiation during embryonic development |
| Q28247901 | The RUNX genes: gain or loss of function in cancer |
| Q35068916 | The cleidocranial dysplasia-related R131G mutation in the Runt-related transcription factor RUNX2 disrupts binding to DNA but not CBF-beta |
| Q42826927 | Tissue specific regulation of VEGF expression during bone development requires Cbfa1/Runx2. |
| Q35931452 | Transcriptional Auto-Regulation of RUNX1 P1 Promoter |
| Q33732988 | Transcriptional corepressor TLE1 functions with Runx2 in epigenetic repression of ribosomal RNA genes |
| Q78419883 | Transcriptional regulation restricting bone sialoprotein gene expression to both hypertrophic chondrocytes and osteoblasts |
| Q73879531 | Tumor necrosis factor-alpha inhibits pre-osteoblast differentiation through its type-1 receptor |
| Q35592741 | Tumor necrosis factor-alpha: molecular and cellular mechanisms in skeletal pathology |
| Q46460319 | Twist is required for establishment of the mouse coronal suture. |
| Q98385867 | Unraveling the mystery of Gaucher bone density pathophysiology |
| Q46573955 | Vibrational stimulation induces osteoblast differentiation and the upregulation of osteogenic gene expression in vitro. |
| Q41819664 | miR-203 and miR-320 Regulate Bone Morphogenetic Protein-2-Induced Osteoblast Differentiation by Targeting Distal-Less Homeobox 5 (Dlx5) |
Search more.